Personalized Vaccines Are Giving More Patients Hope After Brain Cancer Diagnosis


Date:

(MENAFN- Investor Brand Network) Personalized vaccines are giving more brain cancer patients reason to hope, and at UCLA, one tested in clinical trials has helped about two dozen people with glioblastoma live far longer than expected. Doctors are now working to extend that benefit to the thousands of brain tumor patients who need it.

Concurrently, many other firms like CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are investing in developing the next generation of medicines indicated for...

Read More>>

About TinyGems

TinyGems is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 75+ brands within the Dynamic Brand Portfolio IBN: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ; (2) article and editorial syndication to 5,000+ outlets ; (3) enhanced press release enhancement to ensure maximum impact ; (4) social media distribution via IBN to millions of social media followers ; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.

MENAFN16112026000224011066ID1111972430


Investor Brand Network

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story

Search